Header Logo

Connection

Girish Modi to Humans

Back to Details
This is a "connection" page, showing publications Girish Modi has written about Humans.
Girish Modi
Connection Strength
1,076
Humans
  1. The role of atherosclerosis in HIV-associated vasculopathy in young South African stroke patients. HIV Med. 2025 Apr; 26(4):633-642.
    View in: PubMed
    Score: 0,074
  2. Stroke, HIV and the Immune Reconstitution Inflammatory Syndrome in the absence of opportunistic infections. J Neurol Sci. 2024 Feb 15; 457:122880.
    View in: PubMed
    Score: 0,068
  3. Stroke as the index presentation of traditional cardiovascular risk factors and Human Immunodeficiency Virus in a South African population. J Stroke Cerebrovasc Dis. 2024 Feb; 33(2):107529.
    View in: PubMed
    Score: 0,068
  4. Outcome of uncorrected CSF leak and consequent recurrent meningitis in a patient: a case presentation and literature review. Br J Neurosurg. 2020 Oct; 34(5):492-494.
    View in: PubMed
    Score: 0,046
  5. CIDP in a HIV endemic population: A prospective case series from Johannesburg, South Africa. J Neurol Sci. 2016 Apr 15; 363:39-42.
    View in: PubMed
    Score: 0,039
  6. Acute ischaemic stroke: highlighting the need for early intervention. Cardiovasc J Afr. 2013 Apr; 24(3):51.
    View in: PubMed
    Score: 0,032
  7. Management of ischaemic stroke in the acute setting: review of the current status. Cardiovasc J Afr. 2013 Apr; 24(3):86-92.
    View in: PubMed
    Score: 0,032
  8. Non-traumatic myelopathy at the Chris Hani Baragwanath Hospital, South Africa--the influence of HIV. QJM. 2011 Aug; 104(8):697-703.
    View in: PubMed
    Score: 0,028
  9. Intraventricular neurocysticercosis causing acute unilateral hydrocephalus. Afr J Psychiatry (Johannesbg). 2010 Sep; 13(4):315-7.
    View in: PubMed
    Score: 0,027
  10. Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci. 2010 Jan; 1184:154-72.
    View in: PubMed
    Score: 0,026
  11. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
    View in: PubMed
    Score: 0,025
  12. New onset seizures in HIV--seizure semiology, CD4 counts, and viral loads. Epilepsia. 2009 May; 50(5):1266-9.
    View in: PubMed
    Score: 0,024
  13. Is stroke a HIV-related neurologic manifestation? Expert Rev Neurother. 2008 Aug; 8(8):1247-53.
    View in: PubMed
    Score: 0,023
  14. Multiple sclerosis in South Africa. S Afr Med J. 2008 May; 98(5):391-3.
    View in: PubMed
    Score: 0,023
  15. Reduced risk of toxoplasma encephalitis in HIV-infected patients--a prospective study from Gauteng, South Africa. Int J STD AIDS. 2007 Aug; 18(8):555-8.
    View in: PubMed
    Score: 0,022
  16. The frequency and profile of neurology in black South African HIV infected (clade C) patients - a hospital-based prospective audit. J Neurol Sci. 2007 Mar 15; 254(1-2):60-4.
    View in: PubMed
    Score: 0,021
  17. Human immunodeficiency virus associated intracranial aneurysms: report of three adult patients with an overview of the literature. J Neurol Neurosurg Psychiatry. 2008 Jan; 79(1):44-6.
    View in: PubMed
    Score: 0,021
  18. Stroke and HIV--causal or coincidental co-occurrence? S Afr Med J. 2006 Dec; 96(12):1247-8.
    View in: PubMed
    Score: 0,021
  19. Blood pressure-measuring devices in rural South Africa: an audit conducted by the SASPI team in the Agincourt field site. Cardiovasc J S Afr. 2006 Jul-Aug; 17(4):192-6.
    View in: PubMed
    Score: 0,020
  20. Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatry. 2005 Oct; 76(10):1455-6.
    View in: PubMed
    Score: 0,019
  21. Management of HIV-associated focal brain lesions in developing countries. QJM. 2004 Jul; 97(7):413-21.
    View in: PubMed
    Score: 0,018
  22. Motor neuron disease in black African patients at a tertiary care hospital in Soweto, South Africa. J Neurol Sci. 2023 08 15; 451:120710.
    View in: PubMed
    Score: 0,016
  23. Superficial siderosis--case report and review. S Afr Med J. 2003 Mar; 93(3):207-9.
    View in: PubMed
    Score: 0,016
  24. Stroke in black South African HIV-positive patients: a prospective analysis. Stroke. 2003 Jan; 34(1):10-5.
    View in: PubMed
    Score: 0,016
  25. New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis--a clinical, radiological and SPECT scan study. J Neurol Sci. 2002 Oct 15; 202(1-2):29-34.
    View in: PubMed
    Score: 0,016
  26. New-onset seizures in HIV-infected patients. A review and guide to management. S Afr Med J. 2001 Dec; 91(12):1025-6.
    View in: PubMed
    Score: 0,015
  27. Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry. 2001 Apr; 70(4):500-5.
    View in: PubMed
    Score: 0,014
  28. Relations of aortic stiffness with arterial damage beyond brachial pressure are both dependent and independent of central arterial pulsatile load. J Hypertens. 2021 04 01; 39(4):718-728.
    View in: PubMed
    Score: 0,014
  29. New-onset seizures associated with HIV infection. Neurology. 2000 Nov 28; 55(10):1558-61.
    View in: PubMed
    Score: 0,014
  30. Case reports: postpartum cerebral angiopathy in a patient with chronic migraine with aura. Headache. 2000 Sep; 40(8):677-81.
    View in: PubMed
    Score: 0,014
  31. Marked Arterial Functional Changes in Patients With Arterial Vascular Events Across the Early Adult Lifespan. Arterioscler Thromb Vasc Biol. 2020 06; 40(6):1574-1586.
    View in: PubMed
    Score: 0,013
  32. The clinical and genetic characteristics of spinocerebellar ataxia type 7 (SCA 7) in three Black South African families. Acta Neurol Scand. 2000 Mar; 101(3):177-82.
    View in: PubMed
    Score: 0,013
  33. Complementary Impact of Carotid Intima-Media Thickness With Plaque in Associations With Noncardiac Arterial Vascular Events. Angiology. 2020 02; 71(2):122-130.
    View in: PubMed
    Score: 0,013
  34. Carotid intima-media thickness, but not chronic kidney disease independently associates with noncardiac arterial vascular events in South Africa. J Hypertens. 2019 04; 37(4):795-804.
    View in: PubMed
    Score: 0,012
  35. Synthesis, Characterisation and In Vitro Permeation, Dissolution and Cytotoxic Evaluation of Ruthenium(II)-Liganded Sulpiride and Amino Alcohol. Sci Rep. 2019 03 11; 9(1):4146.
    View in: PubMed
    Score: 0,012
  36. A CD99+ primary spinal central PNET in a pregnant patient- therapeutic concerns and issues. Br J Neurosurg. 2019 Jun; 33(3):253-254.
    View in: PubMed
    Score: 0,011
  37. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discov Today. 2016 12; 21(12):1886-1914.
    View in: PubMed
    Score: 0,010
  38. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
    View in: PubMed
    Score: 0,010
  39. Improving drug delivery technology for treating neurodegenerative diseases. Expert Opin Drug Deliv. 2016 07; 13(7):1029-43.
    View in: PubMed
    Score: 0,010
  40. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain. Int J Pharm. 2016 Mar 16; 500(1-2):196-209.
    View in: PubMed
    Score: 0,010
  41. Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
    View in: PubMed
    Score: 0,010
  42. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
    View in: PubMed
    Score: 0,009
  43. Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des. 2015; 21(12):1517-28.
    View in: PubMed
    Score: 0,009
  44. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014 Jul 10; 185:130-8.
    View in: PubMed
    Score: 0,009
  45. Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine (Lond). 2014 Feb; 9(2):331-48.
    View in: PubMed
    Score: 0,009
  46. Cur(Que)min: a neuroactive permutation of curcumin and quercetin for treating spinal cord injury. Med Hypotheses. 2014 Apr; 82(4):437-41.
    View in: PubMed
    Score: 0,009
  47. Patient-controlled analgesia: therapeutic interventions using transdermal electro-activated and electro-modulated drug delivery. J Pharm Sci. 2014 Feb; 103(2):353-66.
    View in: PubMed
    Score: 0,009
  48. A novel pH-sensitive interferon-ß (INF-ß) oral delivery system for application in multiple sclerosis. Int J Pharm. 2013 Nov 18; 456(2):459-72.
    View in: PubMed
    Score: 0,008
  49. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
    View in: PubMed
    Score: 0,008
  50. Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease. AAPS PharmSciTech. 2013 Jun; 14(2):605-19.
    View in: PubMed
    Score: 0,008
  51. Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
    View in: PubMed
    Score: 0,007
  52. In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011 Jan 19; 12(1):694-724.
    View in: PubMed
    Score: 0,007
  53. Self-assembling peptides: implications for patenting in drug delivery and tissue engineering. Recent Pat Drug Deliv Formul. 2011 Jan; 5(1):24-51.
    View in: PubMed
    Score: 0,007
  54. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
    View in: PubMed
    Score: 0,007
  55. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Int J Mol Sci. 2009 Jun 03; 10(6):2510-57.
    View in: PubMed
    Score: 0,006
  56. Differences in the nature of stroke in a multiethnic urban South African population: the Johannesburg hospital stroke register. Stroke. 2009 Feb; 40(2):355-62.
    View in: PubMed
    Score: 0,006
  57. The burden of stroke in Sub-Saharan Africa. Am J Prev Med. 2007 Aug; 33(2):172-3.
    View in: PubMed
    Score: 0,005
  58. Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurol. 2007 Mar; 6(3):269-78.
    View in: PubMed
    Score: 0,005
  59. Accuracy of the Siriraj and Guy's Hospital Stroke Scores in urban South Africans. Stroke. 2007 Jan; 38(1):62-8.
    View in: PubMed
    Score: 0,005
  60. Optic neuritis in an urban black African community. Eye (Lond). 2001 Aug; 15(Pt 4):469-73.
    View in: PubMed
    Score: 0,004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.